JOEL ANDREWS: Open Payments
NPI 1720447394 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,151 in 16 payments from 8 companies in 2025. Trend: 2023 $957 · 2024 $4,728 · 2025 $1,151
Food & beverage: $1,151
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 3 | $314 |
| Adaptive Biotechnologies Corporation | 4 | $230 |
| Janssen Biotech, Inc. | 3 | $169 |
| Incyte Corporation | 1 | $123 |
| PFIZER INC. | 2 | $115 |
| Regeneron Healthcare Solutions, Inc. | 1 | $97 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $88 |
| Legend Biotech USA Inc. | 1 | $16 |
Products named: DARZALEX, clonoSEQ, RYBREVANT, Niktimvo, ELREXFIO, LYNOZYFIC, SYLVANT, CARVYKTI.
Industry payments across GA — which companies pay providers there.
